A clinical and proteomics approach to predict the presence of obstructive peripheral arterial disease: From the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study
- 14 June 2018
- journal article
- research article
- Published by Wiley in Clinical Cardiology
- Vol. 41 (7) , 903-909
Abstract
Background: Peripheral arterial disease (PAD) is a global health problem that is frequently underdiagnosed and undertreated. Noninvasive tools to predict the presence and severity of PAD have limitations including inaccuracy, cost, or need for intravenous contrast and ionizing radiation.Hypothesis: A clinical/biomarker score may offer an attractive alternative diagnostic method for PAD.Methods: In a prospective cohort of 354 patients referred for diagnostic peripheral and/or coronary angiography, predictors of ≥50% stenosis in ≥1 peripheral vessel (carotid/subclavian, renal, or lower extremity arteries) were identified from >50 clinical variables and 109 biomarkers. Machine learning identified variables predictive of obstructive PAD; a score derived from the final model was developed.Results: The score consisted of 1 clinical variable (history of hypertension) and 6 biomarkers (midkine, kidney injury molecule‐1, interleukin‐23, follicle‐stimulating hormone, angiopoietin‐1, and eotaxin‐1). The model had an in‐sample area under the receiver operating characteristic curve of 0.85 for obstructive PAD and a cross‐validated area under the curve of 0.84; higher scores were associated with greater severity of angiographic stenosis. At optimal cutoff, the score had 65% sensitivity, 88% specificity, 76% positive predictive value (PPV), and 81% negative predictive value (NPV) for obstructive PAD and performed consistently across vascular territories. Partitioning the score into 5 levels resulted in a PPV of 86% and NPV of 98% in the highest and lowest levels, respectively. Elevated score was associated with shorter time to revascularization during 4.3 years of follow‐up.Conclusions: A clinical/biomarker score demonstrates high accuracy for predicting the presence of PAD.Keywords
Funding Information
- Prevencio, Inc.
- Dennis and Marilyn Barry fellowship in cardiology research
- Hutter Family Professorship in Cardiology
- Ruth and James Clark Fund for Cardiac Research Innovation.
This publication has 25 references indexed in Scilit:
- Expression of midkine, a multifunctional cytokine, in human atherosclerotic plaquesEuropean Journal of Internal Medicine, 2013
- An evidence-based score to detect prevalent peripheral artery disease (PAD)Vascular Medicine, 2012
- Interleukin-23 serum levels in patients affected by peripheral arterial diseaseClinical Biochemistry, 2012
- Regression Shrinkage and Selection via The Lasso: A RetrospectiveJournal of the Royal Statistical Society Series B: Statistical Methodology, 2011
- Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerabilityBasic Research in Cardiology, 2010
- The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjectsJournal of Vascular Surgery, 2008
- Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery diseaseAtherosclerosis, 2006
- Least angle regressionThe Annals of Statistics, 2004
- The intra- and interobserver variability of ankle–arm blood pressure index according to its mode of calculationJournal of Clinical Epidemiology, 2003
- Overexpression of Eotaxin and the CCR3 Receptor in Human AtherosclerosisCirculation, 2000